PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsIron dextran
Iron dextran
Ferric Oxyhydroxide, Ferrlecit, Infed, Velphoro, Venofer (iron dextran) is an unknown pharmaceutical. Iron dextran was first approved as Infed on 1982-01-01.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
ferrlecitNew Drug Application2025-06-06
infedNew Drug Application2024-10-14
iron dextranNew Drug Application2025-01-08
velphoroNew Drug Application2024-12-12
venoferNew Drug Application2022-07-25
venofer (iron sucrose)New Drug Application2024-04-19
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Ferric Oxyhydroxide, Velphoro, Vifor Fresenius
106248552034-11-26DP
112349382034-11-26DP
114462522034-11-26DP
95612512030-01-23DPU-1468
106823762028-11-13DP
106953672028-11-13DP
109258962028-11-13DP
109258972028-11-13DP
109330902028-11-13DP
110137612028-11-13DP
110137622028-11-13DP
ATC Codes
No data
HCPCS
Code
Description
J1750
Injection, iron dextran, 50 mg
Clinical
Clinical Trials
2384 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
UrolithiasisD052878—N20-N23————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameIron dextran
INN_
Description
Iron supplements, also known as iron salts and iron pills, are a number of iron formulations used to treat and prevent iron deficiency including iron deficiency anemia. For prevention they are only recommended in those with poor absorption, heavy menstrual periods, pregnancy, hemodialysis, or a diet low in iron. Prevention may also be used in low birth weight babies. They are taken by mouth, injection into a vein, or injection into a muscle. While benefits may be seen in days, up to two months may be required until iron levels return to normal.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL1201544
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID87PZU03K0K (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Iron dextran
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 5,613 documents
View more details
Safety
Black-box Warning
Black-box warning for: Iron dextran
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
9,774 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use